NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation
Germline mono-allelic loss of the tumour suppressor NF1 predisposes patients to the development of benign lesions but rarely further progression into cancer development. Here the authors use mouse models to show that an NF1 heterozygous microenvironment accelerates the formation of benign tumours bu...
Enregistré dans:
Auteurs principaux: | Jean-Philippe Brosseau, Chung-Ping Liao, Yong Wang, Vijay Ramani, Travis Vandergriff, Michelle Lee, Amisha Patel, Kiyoshi Ariizumi, Lu Q. Le |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9469062130ae408ba5616d707d78a78d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease
par: Julia Neitzel, et autres
Publié: (2021) -
LncRNA NR038975, A Serum-Based Biomarker, Promotes Gastric Tumorigenesis by Interacting With NF90/NF45 Complex
par: Sisi Wei, et autres
Publié: (2021) -
Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy
par: Veronica Rendo, et autres
Publié: (2020) -
Developmental stability covaries with genome-wide and single-locus heterozygosity in house sparrows.
par: Carl Vangestel, et autres
Publié: (2011) -
Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers
par: Mandar Deepak Muzumdar, et autres
Publié: (2016)